Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
10 July 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin...
List view / Grid view
10 July 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin...
Lonza, a world leader in gene expression and biopharmaceutical development of protein therapeutics, announced today the launch of the new GS Xceed™ Gene Expression System.
9 July 2012 | By European Medicines Agency (EMA)
The EMA has been notified by Sanofi-aventis of its decision to withdraw its marketing authorisation application for Mulsevo...
9 July 2012 | By B&W Tek
B&W Tek, Inc., is thrilled to introduce their exciting and intuitive new website...
9 July 2012 | By Phenomenex Inc
The SecurityGuard™ ULTRA UHPLC column protection system has been recognized as one of the top innovations of 2012...
9 July 2012 | By Boehringer Ingelheim
"We are very pleased to sponsor the joint research programs..."
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
6 July 2012 | By Eli Lilly and Company
Eli Lilly and Company has met the United States FDA requirements for pediatric exclusivity for Cymbalta®...
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
5 July 2012 | By Boehringer Ingelheim
Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health...
5 July 2012 | By Amgen
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco...
5 July 2012 | By Biogen Idec
Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
CAMO Software & up to data have partnered...
3 July 2012 | By Abbott
Abbott has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs)...